| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |